Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update ; volume:20 ; number:4 ; day:25 ; month:7 ; year:2023 ; pages:914-931 ; date:7.2023
Neurotherapeutics ; 20, Heft 4 (25.7.2023), 914-931, 7.2023
- Urheber
-
Yadollahikhales, Golnaz
Rojas, Julio C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-023-01405-0
- URN
-
urn:nbn:de:101:1-2023110610473798617322
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yadollahikhales, Golnaz
- Rojas, Julio C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amyloid PET imaging: applications beyond Alzheimer’s disease
News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Updates on mouse models of Alzheimer’s disease
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Updates on mouse models of Alzheimer’s disease
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Updates on mouse models of Alzheimer’s disease
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress